Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Multi Units Luxembourg SICAV - Amundi STOXX Europe 600 Healthcare UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €157.06 |
52 Week High | €167.78 |
52 Week Low | €126.80 |
Beta | 0 |
11 Month Change | -3.79% |
3 Month Change | 0.20% |
1 Year Change | 14.86% |
33 Year Change | 28.32% |
5 Year Change | 62.29% |
Change since IPO | 82.93% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LHTC | DE Capital Markets | DE Market | |
---|---|---|---|
7D | -1.7% | 1.4% | 1.1% |
1Y | 14.9% | 30.5% | 10.7% |
Return vs Industry: LHTC underperformed the German Capital Markets industry which returned 30.5% over the past year.
Return vs Market: LHTC exceeded the German Market which returned 10.7% over the past year.
Price Volatility
LHTC volatility | |
---|---|
LHTC Average Weekly Movement | 1.9% |
Capital Markets Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LHTC has not had significant price volatility in the past 3 months.
Volatility Over Time: LHTC's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | n/a | www.amundietf.lu/en/professional/products/equity/lyxor-stoxx-europe-600-healthcare-ucits-etf-dist/lu2082997516 |
Multi Units Luxembourg SICAV - Amundi STOXX Europe 600 Healthcare UCITS ETF is an exchange traded fund launched by Amundi Luxembourg S.A.. The fund is managed by Amundi Asset Management SAS. It invests in the public equity markets of Europe.
Multi Units Luxembourg SICAV - Amundi STOXX Europe 600 Healthcare UCITS ETF Fundamentals Summary
LHTC fundamental statistics | |
---|---|
Market cap | €903.26m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LHTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LHTC income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LHTC perform over the long term?
See historical performance and comparison